| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  SÊMEIA [Automatic translation follows] Digital technology supporting healthcare professionals for everyone, everywhere Sêmeia designs and implements support solutions for patients suffering from serious or chronic illnesses. We apply the latest artificial intelligence technologies (deep learning, sequence mining, etc.) to improve the patient experience. Their support is personalized thanks to predictive models of patient journeys, based in particular on Health Insurance reimbursement data. Sêmeia solutions identify the patients most at risk (treatment cessation, re-hospitalizations, complications, etc.) and critical periods (taking certain medications, time after hospitalization, etc.) to intervene with them in an appropriate manner. efficient and appropriate. Associated with our predictive models, … Type: | 34 | 9 | 31 | 53 |
 |  Osivax Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company … Tags: FrenchTech2030 Type: | 22 | 11 | 13 | 53 |
 | Ganymed Robotics Orthopedics for visionaries There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. It's going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldn't be a direct result of the surgeon's state of mind. We believe it's possible to create tools that will improve both patient … Tags: FrenchTech2030 Type: | 21 | 11 | 10 | 53 |
 | MEDES - Institute for Space Medicine and Physiology Explorer et Innover pour la Santé Based in Toulouse (France), MEDES is a group of economic interest created in 1989, which missions are to develop an expertise in the medical supervision of manned flights and the preparations for future interplanetary manned missions and to apply the results of space research on the areas of Healthcare. In order to meet space and clinical research needs, MEDES runs a centre for medical experimentation, the Space Clinic. MEDES has been also invested for more than 15 years in many telemedicine or medical research projects. space, telemedicine, and information technologies Type: | 15 | 4 | 8 | 54 |
 | CUTISS AG Personalized & bioengineered human skin tissue therapy for patients with severe burns and skin injuries Our mission: to give patients back more of their own skin to make them well again. CUTISS is a Swiss clinical-stage life sciences company focussed on regenerative medicine, skin tissue engineering, and skin pigmentation. We are developing the first personalized and automated skin tissue therapy offering life-saving and life-changing medical treatments for patients with severe skin injuries. Our lead product denovoSkin promises to take skin surgery to the next level and revolutionize current treatments. It is a bio-engineered and personalized dermo-epidermal human skin graft, currently … Type: | 6 | 1 | 5 | 54 |
 | NG BIOTECH Rapid, mobile, connected diagnostics At NG Biotech, we develop, manufacture and commercialise rapid, mobile and connected diagnostics to modernize diagnosis practice worldwide. NG Biotech is a French company specialized in Research & Development, Manufacturing and Marketing of a new generation of "multiplex", "quantitative" and "connected" rapid diagnostics for biomarker analysis and/or therapy monitoring at the Point of Care. NG Biotech’s patented platform is rapid, mobile and connected. It allows to simultaneously analyse up to 9 biomarkers from a biological direct sample such as a single finger-prick drop of blood. The results can be sent via smartphone within five minutes. NG … Type: | 9 | 3 | 5 | 56 |
 | Apricity Fertility Less Stress, More Success Apricity is the UK's first virtual fertility clinic, a next-generation experience for less stress and more success 1 in 6 couples and over 3 million people in the UK struggle to conceive. Treatment exists, but is often associated with stress and uncertainty. We don't believe it has to be this way. Apricity challenges the traditional fertility treatment journey, leveraging AI and technology with personalised human care to create a truly patient-centric experience. We are reimagining fertility care, maximising chances of pregnancy success and supporting patients at every step. ▶️ Virtual clinic model with at home diagnostic … Type: | 11 | 4 | 9 | 57 |
 | BioIndustry Association (BIA) The award-winning trade association for the innovative life sciences and biotech companies in the UK The BioIndustry Association (BIA) is the voice of the innovative life sciences and biotech industry, enabling and connecting the UK ecosystem so that businesses can start, grow and deliver world-changing innovation. BIA is a trade association with 490+ member companies including: - Start-ups, biotechnology and innovative life science companies - Pharmaceutical and technological companies - Universities, research centres, tech transfer offices, incubators and accelerators - A wide range of life science service providers: investors, lawyers, IP consultants, IR agencies BIA is the key thought leader … Type: | 9 | 4 | 6 | 58 |
 | Campus Cyber Ensemble, au service d’une grande nation cyber 🇫🇷🇪🇺 Ensemble, au service d’une grande nation Cyber 🇫🇷🇪🇺 Type: | 90 | 52 | 56 | 58 |
 | Moon Surgical Empowering the Surgeon Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. medical device, minimally invasive surgery, digital surgery, comanipulation, AI, Machine Learning, Surgery, Laparoscopy, and Surgical Robotics Tags: FrenchTech2030 Type: | 13 | 7 | 7 | 58 |
 | ANEPF - Association Nationale des Étudiants en Pharmacie de France [Automatic translation follows] 55 years 33,000 students 24 faculties Let's support tomorrow's pharmacists today Founded in 1968, the National Association of Pharmacy Students of France (ANEPF) represents more than 33,000 students from the 24 faculties of pharmacy. The fields of activity of our association extend to all sectors of the pharmaceutical world (Industrial, Pharmacy, Hospital), both on the professional and student side. Our commitments materialize through different missions: Promote and sustain links between health institutions/professionals and students, their future colleagues, Represent all pharmacy students before university and ministerial bodies, by participating in the development of reforms governing the pharmaceutical world, … Type: | 26 | 5 | 18 | 59 |
 | BIOSYNEX Diagnostics Innovation for Biotherapies BIOSYNEX was founded in 2005 and is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. By staying close to our customers and business partners we are aware of the needs and expectations they may have of our products and services. Listening to their voice, together with the help of our Research and Development laboratories in France and our state of the art manufacturing facilities, allows us to identify new applications in rapid testing, develop and launch innovative products and provide high quality services. Our aim is to … Type: | 1 | 0 | 1 | 59 |
 | AQEMIA Scale Drug Discovery with Quantum-inspired Physics and AI Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates. We are hiring! Check our career website: https://jobs.lever.co/aqemia.com Blog Posts on: https://medium.com/aqemia drug discovery, in silico drug discovery, Pharmaceutical R&D, Artificial intelligence, HPC developer, drug hunting, software developer, quantum, and drug design Tags: FrenchTech2030 Type: | 28 | 17 | 16 | 59 |
 | Qubit Pharmaceuticals Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. No target is undruggable. Our proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex. Drug Discover, Computational Chemistry, Molecular Dynamics Simulation, and Quantum Physics Tags: FrenchTech2030 Type: | 46 | 17 | 36 | 59 |
 | ICOSA Intellectual Property to support your business ICOSA is an IP Law firm dedicated to Life Sciences, Chemistry and Medical Device. The specificity of the ICOSA group indeed lies in its ability to provide solid IP and technological expertise, owing to a pluridisciplinar and fully qualified team of professionals. For ensuring that our clients will always benefit from high value-added services, the founding partners of ICOSA have deliberately decided to focus their activity on their life sciences expertise. Our areas of expertise thus include Biotechnologies, Pharmaceutical Chemistry, Medical devices, Greentech sectors, Cosmetics and Food Processing & Agriculture. ICOSA’s teams are formed … Type: | 42 | 9 | 36 | 60 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 9 | 8 | 1 | 62 |
 | Académie Nationale de Chirurgie [Automatic translation follows] The National Academy of Surgery wants to contribute to meeting the public health challenges we face. Role and objectives of the National Academy of Surgery Moral responsibility in all matters concerning surgeryGuardian of its history Witness its evolution Guarantor of its ethics Careful and rigorous evaluation of the development of technical aspects of the surgical art and their changes Definition of good surgical practices: references, recommendations, strategies Control of the conditions of the specific exercise of surgery Appreciation of the training and recruitment of surgeons Type: | 18 | 7 | 0 | 62 |
 | INVIVOX Never Stop Sharing The first healthcare platform dedicated to sharing knowledge and experience between healthcare players. #health #medicaleducation French startup created in 2016, Invivox has allowed more than 44,000 healthcare professionals to be trained in 2020. Our primary mission: To democratize and facilitate access to knowledge in healthcare to improve the quality of patient care worldwide. Our vision: To become the reference for knowledge sharing between healthcare players. If you would like to know more about our offer, visit: https://invivox.com/ #NeverStopSharing e-medecine, Medical Training, In Situ Training, Digital Health, e-health, Training inside the OR, Medical Education, Medical Mentoring, Peer to … Type: | 18 | 6 | 13 | 63 |
 | Depixus Depixus® is pioneering a powerful new technology based on magnetic force spectroscopy, that reveals biomolecular interactions. MAGNATM enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies. Our MAGNA technology goes beyond decoding the static genetic code to reveal the dynamics of the genome that control health and disease. Single molecule analysis, RNA Drug Discovery, Protein-protein Interaction Analysis, Biophysics, Drug Discovery, Compound Screening, biomolecular interactions, and interactomics Type: | 1 | 1 | 0 | 63 |
 | B.Conseil - Financement de l'Innovation🌱 [Automatic translation follows] Proper management of the Research Tax Credit | 1000+ customers | 60 talents | Paris Toulouse Lille Lyon Strasbourg Experts in financing innovation: We offer entrepreneurs and business leaders the means to finance risk-taking in the development of their new products. We act to guarantee them the best possible financing in the least time-consuming and anxiety-inducing way possible. Our goal is to contribute on our scale to a better world as a facilitator for the emergence of new know-how and products. Our expertise in different R&D and Innovation financing schemes allows us to financially encourage innovation driven … Type: | 11 | 3 | 9 | 64 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. Type: | 9 | 3 | 6 | 64 |
 | Antenor [Automatic translation follows] Independent Human Resources consultancy founded 27 years ago, with 20 expert collaborators specializing in Life Sciences (Pharma/Biotech, MedTech, Diagnostic Analysis, Cosmetics/Chemistry), and medico-social and health activities (Public Hospitals, ESPIC and Private Clinics, Occupational Health) and by profession, our proposal is global and makes it possible to respond to the needs and projects of recruitment, delegation and temporary work, internal mobility and evaluation. Our approach is based on values and a methodology common to all, such as the systematic evaluation of candidates or the guarantee of services provided to our clients. Our interventions are delivered according to principles … Type: | 5 | 0 | 3 | 66 |
 | BRIC-BoRdeaux Institute of onCology Cliniciens et chercheurs réunis à Bordeaux pour la recherche contre le cancer. Unité de recherche sous les tutelles Inserm et Université de Bordeaux, composée de 11 équipes de recherche sur la thématique cancer : Team A. Bikfalvi / L. Brisson / T. Mathivet Tumor and vascular biology laboratory. Team M. Khatib / F. Delom Reprogramming tumor activity and associated microenvironment (RYTME). Team V. Moreau / F. Saltel Liver cancers and tumor invasion (LCTI). Team C. Varon Helicobacter- associated digestive cancers, cancers stem cells and therapeutic strategies. Team H. Rezvani / M. Beylot Barry Translational Research in Oncodermatology and orphan skin … Type: | 20 | 1 | 2 | 66 |
 | Posos Posos is the world's most advanced artificial intelligence platform dedicated to medical prescriptions. Founded in 2018, Posos is a MedTech company that has built the world's most advanced artificial intelligence platform dedicated to medical prescriptions. It seamlessly integrates into a hospital’s electronic medical records, enabling healthcare prescribers to use AI to prescribe in real-time, based on the best recommendations. Co-created by Posos' pharmacists and engineers, the platform has received approval from health authorities in France. Its powerful AI assistant speeds up and optimizes the prescribing process, which is currently very time-consuming and approximate within EHR. Posos can drive massive patient … Type: | 28 | 14 | 18 | 67 |
 | Pharmaceutiques [Automatic translation follows] Reference information for the pharmaceutical sector Since 1992, economic, political and regulatory news from players in the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Report on major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files Type: | 55 | 11 | 50 | 69 |
 | Sonio Securing pregnancy care Sonio is the next generation Women’s Health Practice Management & Reporting Software. Perform every prenatal examination to your highest quality standards with Sonio platform, powered by AI1. Empower your ultrasound practitioners and readers, clinical executives, and IT with a robust, intuitive and easy-to-use platform. Improve efficiency, quality assurance and clinical excellence at each step of the patient’s pregnancy journey. 1AI capabilities are brought through our FDA 510(k) cleared Sonio Detect product and thanks to our MDR-CE marked Sonio Expert product. prenatal diagnosis, prenatal screening, SaaS, prenatal ultrasound sharing, AI, maternal fetal medicine, and prenatal ultrasound Type: | 15 | 10 | 7 | 69 |
 | Tilak Healthcare You Play, We Care. At Tilak, our vision is to transform the way we monitor chronic eye conditions. Our mission is to empower patients with fun and easy-to-use apps that help them (and their doctors’!) better manage their diseases. Founded in 2016 by Pr. José-Alain Sahel (opthalmologist) and Edouard Gasser (ex-Gameloft), Tilak's DNA combines medical expertise with gaming mastery. “You Play, We Care.” Our product is OdySight, the world's first medical mobile app for vision monitoring supported by a national healthcare system. Since its launch on the French market in 2018, OdySight has been prescribed to 15 000 patients, most … Type: | 36 | 12 | 22 | 70 |
 | FineHeart A Healthier Life With Every Beat FineHeart is a clinical stage medical device company based in Bordeaux, France. Its innovative product, FLOWMAKER®, has the potential to treat 200,000 patients with advanced heart failure each year. FineHeart will initially target the 50,000 most severe patients who are eligible for cardiac assistance. Initial estimates value this market segment to be worth over US$5 billion. FineHeart was founded by CEO Arnaud Mascarell and a team of internationally renowned cardiac surgeons and electro-physiologists, including Dr. Stephane Garrigue, CSO and inventor of the concept, and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy (CRT). The … Type: | 25 | 6 | 21 | 71 |
 | Tours Événements [Automatic translation follows] Royal Destination Experience The Local Public Company SPL Tours Événements is in charge of operating the Palais des Congrès and the Tours Expo Park. It hosts an average of 300 events of all types and 800,000 delegates, spectators or visitors. It produces around ten events for the general public or professionals, including the Tours Fair and the Mondial du Fromage. In the heart of the Loire castles, 1 hour from Paris, Tours is the ideal location for congresses, conventions, seminars and trade shows. Type: | 40 | 6 | 36 | 72 |
 | Angels Santé The leading European Business Angels network in healthcare investment Europe’s number one Business Angel Network for Health Angles Santé investors provide their funds and expertise to start-ups with strong potential to support their launch and development. Our mission at Angels Santé: to detect European start-ups that meet the challenges of our health systems with economically responsible solutions and strong medical benefits, to boost seed-stage development by providing direct capital, expertise and networks, to mobilize non-specialized investors towards health investment to meet the needs of ambitious projects. Our members invest in healthcare projects that they understand, thanks to their expertise and … Type: | 60 | 11 | 45 | 73 |
 | HighLife Transeptal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients. | 3 | 1 | 1 | 73 |
 | Qarnot More IT, less energy, less carbon! Qarnot is a french company, incorporated in 2010, providing its clients with a unique solution to drastically reduce their carbon footprint linked to their digital activities. Instead of concentrating servers in datacenters, our strategy relies on a computing power infrastructure distributed in buildings (offices, housings, public facilities, factories, warehouses) where huge amounts of heat generated by IT servers can be locally and directly valued. This alternative way brings a global and important cost, risk and carbon footprint reduction of our clients digital infrastructure compared to the traditional data center approach, especially concerning high performance … Tags: FrenchTech2030 Type: | 55 | 20 | 42 | 82 |
 | Synapse Medicine Achieving Medication Success with Clinical Decision Support At Synapse Medicine, we believe in medication success, and are dedicated to creating the technology that makes it possible for everyone. To achieve this goal, we have built an extensive global knowledge base for medication using algorithms to ensure the most reliable, up-to-date data. On the front-end, Synapse Medicine provides a SaaS platform and UI components that are used to prescribe, dispense, and manage medications across the entire patient journey. Synapse is working with world-leading hospitals and digital health companies in the United States, Europe, and Japan to transform today’s medication regimens into … Type: | 19 | 10 | 14 | 82 |
 | Enterome Delivering the promise of immunotherapy We are a clinical stage biopharmaceutical company developing developing breakthrough immunomodulatory drugs for the treatment of cancer and inflammatory diseases. We have developed two highly promising pipelines of clinical and pre-clinical candidates with a focus on cancer and auto-immune diseases: - OncoMimicsTM: highly effective, off-the-shelf therapeutic vaccines against cancers (EO2401, EO2463). EO2401 is in Phase 1/2 clinical trials in patients with glioblastoma and adrenal tumors. EO2463 is in a Phase 1/2 clinical trial for indolent non-Hodgkin B-cell lymphomas. - EndoMimicsTM: a pipeline of next generation bioactives acting like human hormones or cytokines for the treatment … Tags: FrenchTech2030 Type: | 10 | 4 | 5 | 82 |
 | COLTENE Micro-Mega [Automatic translation follows] 🇫🇷 French designer and manufacturer since 1905 💪 For dental professionals | 🌍 Global Supplier The MICRO-MEGA company, whose original activity dates back to 1905, is internationally recognized for the design, manufacturing and marketing of medical devices intended for dental surgery. Its root canal and obturation instruments, its handpieces and contra-angles and its hygiene devices bear witness to its unique technical and scientific know-how and the impeccable quality of its endodontic products made in France. medical, dentistry, dental, and endodontics Type: | 9 | 1 | 4 | 83 |
 | ID SOLUTIONS ID SOLUTIONS offers comprehensive Molecular Typing Assays using DigitalPCR for Oncology Diagnostics Our mission To provide innovative, reliable and standardized tools for oncology diagnostic. Research on circulating DNA from liquid biopsy, tumor DNA from solid biopsies. Our team is of molecular biology specialists with more than 20 years of expertise in nucleic acid extraction, molecular biology and oncology. Our proposals To offer a complete molecular typing solution, standardized operating procedures and custom development to improve diagnosis in oncology. biologie moléculaire, diagnostic oncologique, ADN circulant, biopsie liquide, PCR, Digital PCR, Multiplexing, Covid-19, and SARS-CoV-2 | 4 | 2 | 2 | 84 |
 | Robocath INTUITIVE VASCULAR ROBOTICS Robocath is a french medtech which designs, develops and commercializes robotic solutions to treat cardiovascular diseases. R-OneTM is the first european robotic-assisted solution for PCI. The company obtained the CE-mark for R-OneTM in February 2019. It is designed to operate with precision and perform specific movements creating better interventional conditions (radioprotection). Thanks to its open architecture, R-OneTM is compatible with market leading devices and cath labs. Robocath aims to become the world leader in vascular robotics and develop the remote treatment of vascular emergencies, guaranteeing the best care pathway for all. We are convinced that the future … Type: | 13 | 5 | 7 | 87 |
 | Ospi (Groupe PSIH et Collective Thinking) [Automatic translation follows] Data and AI for health Ospi, born from the merger between the PSIH Group and Collective Thinking, is a key player in medical coding, clinical research and quality of care. Software, Health, Business Intelligence, BI, Hospital, Data Hosting, Data Science, EDS, and Cybersecurity Type: | 24 | 1 | 21 | 87 |
 | Innovation e-Santé Sud [Automatic translation follows] The digital partner of healthcare players ieSS carries out its activities in the health, medico-social and social fields. Its aim is to improve patient pathways, through the deployment of e-health solutions in the PACA region. e-health, emergencies, quality, identity-vigilance, coordination, software, and digital Type: | 8 | 3 | 8 | 87 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 13 | 5 | 9 | 90 |
 | CorWave CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up … Tags: FrenchTech120 Type: | 24 | 10 | 22 | 91 |
 | INCEPTO We co-create and distribute AI algorithms for Medical Imaging on a single platform. Saving time, Saving lives, Together. We co-create with medical centers IA applications for radiology. Healthcare professionals are now overwhelmed by the volume of patients and images. They need new tools. As safeguards of our Healthcare system, they need to be empowered and to participate in the AI production process. This is our mission through our co-creation projects. We distribute the world's top applications via a unified platform. Hundreds of start-ups have embarked on this adventure. They all want to produce AI to answer a specific clinical question. … Tags: FrenchTech2030 Type: | 26 | 12 | 19 | 91 |
 | Crossject Expert des médicaments d'urgence auto-administrés Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal … Type: | 16 | 7 | 1 | 94 |
 | IHU LIRYC - Heart rhythm disease Institute 🔬 Liryc is an international research, clinical and teaching centre focusing on heart rhythm diseases. The Heart Rhythm Disease Institute (French: L'Institut des maladies du RYthme Cardiaque), is one of 6 French university hospital institutions created in 2011 as part of the investments in the future program ("Investissements d'avenir") to boost medical research and innovation. This institute, created by Professor Michel Haissaguerre along with cardiology teams of the University Hospital of Bordeaux, unites multiple specialties around cardiac electrophysiology from research on ionic channels (microgenerators producing electric flows in cells) to whole heart and patient care. LIRYC is a basic research, … Type: | 22 | 5 | 2 | 98 |
 | Cousin Surgery Creating tomorrow's surgery together Cousin Surgery offers innovative implants around the world to advance visceral surgery and spine surgery. Cousin Surgery relies on unique expertise in the world of implantable textiles and great creativity, in close collaboration with surgeons. Our areas of innovation: preserve mobility and reduce postoperative pain. Cousin Biotech is the legal manufacturer of the medical devices proposed by Cousin Surgery. Textile medical devices, Spine surgery, Visceral surgery, Obesity surgery, Uro-gynaecology surgery, Hernia repair, and Manufacturing Type: | 8 | 4 | 5 | 100 |
 | Novaxia [Automatic translation follows] Our mission ? Give everyone the means to sustainably transform the city! Novaxia is a leader in real estate development capital. Its job: to enhance investors’ savings by bringing real estate to life. With dual expertise in finance and real estate, Novaxia has developed a unique method which reconciles the interests of the different stakeholders involved in a project: investors, owners, elected officials and communities, landlords. Its objective: to benefit all stakeholders from the creation of value resulting from the recycling of obsolete urban assets (buildings, warehouses, wastelands) and the creation of living spaces. Each project is … Type: | 67 | 24 | 46 | 101 |
 | Femmes de Santé [Automatic translation follows] 1st collective of women and men in Health. To join him: https://collectif.femmesdesante.fr/candidature The first collective of women (and men) in Health. The Women in Health collective's mission is to co-build a fairer system, because it is more egalitarian, and to advance health through collective intelligence, thanks to sorority. Femmes de Santé is an initiative supported and financed by the start-up hkind. The collective is not an association, it benefits from an organizing committee and does not receive donations. To be part of the collective, you must: - be sponsored or sponsored by one of the members of … Type: | 31 | 10 | 30 | 102 |
 | l'Opinion [Automatic translation follows] Liberal daily // politics, economy, international Launched in May 2013 by Nicolas Beytout, Opinion is a liberal, pro-business and pro-European media. With a team of 40 people, including 30 recognized journalists, Opinion covers political, economic and international news with a committed editorial line. Today, Opinion has more than 1 million unique visitors to its site and 42,000 copies distributed. Written press, Internet, Video, Economy, Politics, and International Type: | 83 | 47 | 43 | 104 |
 | Orphalan At Orphalan we strive to develop rare disease treatments to improve patients lives. Transforming Rare Disease Treatment At Orphalan we identify, develop, and provide access to innovative treatments for patients with rare diseases to make a positive and meaningful difference. | 3 | 2 | 2 | 106 |
 | UI Investissement [Automatic translation follows] Together, invest for a better future Specialist in the development of unlisted French companies, UI has been committed and invested, for more than 50 years, alongside managers of growing SMEs and mid-caps to create and develop economically and sustainably successful companies. UI Investissement manages nearly 1.5 billion euros in assets and invests with 300 managers in sectors of activity essential to society such as health, agro-business or industry and services . Development and transmission capital, the historic heart of UI's activity, represents more than half of the assets under management and allows more than 50 companies to … Type: | 89 | 38 | 35 | 109 |
 | Préfecture de la région Bourgogne-Franche-Comté, préfecture de la Côte d’Or [Automatic translation follows] Account of the prefecture of the Burgundy-Franche-Comté region, prefecture of Côte-d'Or. Find on the page of the prefecture of Côte-d'Or and the Burgundy-Franche-Comté region the job offers to be filled within our services, the action of the State in the territory or even the administrative news for businesses. Type: | 40 | 12 | 30 | 109 |
 | Recare We are reshaping discharge management Recare is a web-based, digital platform that facilitates an effective patient transfer from hospital to care providers. Our smart search tool sends targeted requests to potential providers and enables real-time, secure communication between both sides. The process is faster and more transparent for all - hospital staff, care providers, and patients. Type: | 5 | 1 | 4 | 111 |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 70 | 21 | 54 | 112 |
 | EURAXI Conception et réalisation de vos projets d'Etudes Cliniques, Registres, Programmes d'Accès précoces, Home Nursing 🚀✨ Euraxi (CRO) is a project management specialist in the health sector, assisting clients with their projects since 1986. Our organisation and service offer have been perfectly tailored to meet the precise needs of our clients. We can take on all or part of your operations thanks to our multidisciplinary team. This team is organised into specialised units and is guided by the risk management and quality procedures inherent to the requirements of your projects. - Clinical Operations - Data Management, eTools & Statistics - Medical … Type: | 1 | 1 | 1 | 115 |
 | CLINACT Contract Research Organisation CLINACT, a MultiHealth Group company, is a Contract Research Organisation (CRO) assisting you in your health products development: pharmaceutical, medical devices, biotechnology, cosmetics, nutrition... With more than 20 years of experience, CLINACT provides its expertise for large range of innovative services: - Clinical operations - Biometrics - Medical and regulatory affairs - Pharmacovigilance, medical device vigilance and other vigilances - E-tools : Clinfile - Outsourcing and recruting : TempoPHARMA - Professional Training : FORMATIS This range of services fully covers industrials or academic organisations' requirements. As a MultiHealth company, CLINACT can also provide specific services withtout any … Type: | 5 | 0 | 5 | 118 |
 | SYSNAV SYSNAV provides unparalleled motion tracking for better safety and healthcare decisions. We develop high precision solutions for motion measurement and location tracking by leveraging our patented magneto-inertial navigation technology. We design trackers and wearables embedding unique sensor fusion algorithms to deliver reliable 3D motion and trajectory calculation for a variety of challenging environments in pharma, heavy industries, defense & security and automotive. Using our solutions, customers can accelerate clinical trials, enhance the safety of personnel on their facilities, conduct rescue operations, or increase the reliability of vehicle positioning systems for autonomous driving. Founded in 2008, with innovation at the core … Type: | 19 | 4 | 16 | 119 |
 | Inserm Transfert Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health. Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of … Type: | 57 | 23 | 40 | 121 |
 | BIOASTER Disrupting Healthcare - De-risking Innovation - Transforming Technologies BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of … Type: | 20 | 7 | 13 | 123 |
 | BioLabs Premier network of co-working spaces for life science startups BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. coworking, biotech, and pharmaceutical Type: | 40 | 18 | 30 | 123 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 6 | 2 | 6 | 124 |
 | Wandercraft Ordinary life for Extraordinary people We're hiring ! https://wandercraft.welcomekit.co/ Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US. Atalante is not only an exoskeleton. Atalante allows patients to stand up, without crutches. Atalante allows patients to finally be able … Tags: FrenchTech2030 Type: | 37 | 17 | 19 | 125 |
 | Direction de la sécurité sociale [Automatic translation follows] The Social Security Directorate (DSS) is responsible for developing and implementing policies relating to Social Security: health insurance, work accidents and occupational illnesses, retirement, family and autonomy. It depends on several ministers: the ministers in charge of Health, Solidarity, Labor and Public Accounts. The DSS is responsible for the financial balance of the social accounts and as such prepares, each year, the social security financing law (LFSS) and ensures its application. It manages the public social security service including the organizations responsible for implementing these policies: the national funds of the general system (CNAM, CNAF, CNAV, ACOSS, … Type: | 7 | 4 | 3 | 125 |
 | Andera Partners The Power of And Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage over €3.6 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion, Andera Croissance, Andera Co-Invest), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to our investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our … Type: | 31 | 17 | 18 | 126 |
 | UniHA [Automatic translation follows] UniHA is a cooperative of hospital buyers. 1st French public buyer in the health sector. UniHA, the leading public buyer in the health sector, is a purchasing group for public hospitals. With an annual amount of 6 billion euros in purchases, UniHA brings together nearly 1,370 hospital establishments, 123 regional hospital groups (GHT) and can serve all public health establishments. With its 140 employees and hundreds of supplier companies, UniHA helps make purchasing a lever for overall performance to support transformations and innovations in the health system, positioning itself as a strategic player in health. --- Find … Type: | 24 | 2 | 24 | 126 |
 | Okantis [Automatic translation follows] Okantis supports you in the transformation of your information system. Okantis is a public interest group specializing in digital health for over 35 years; based in Limoges and Poitiers and mobilizing nearly 200 expert collaborators throughout France, including overseas territories and territories, Okantis pools with its members a galaxy of high-performance services allowing them to deploy, maintain, train and interconnect software and management systems. information from healthcare establishments. Approved HDS health data host and third-party digital archiver. In a spirit of public service, our cooperation group acts so that the information system constitutes an efficient and innovative … Type: | 20 | 6 | 15 | 130 |
 | Health Data Hub [Automatic translation follows] The one-stop shop for access to health data in France - We are recruiting! The HDH is a state-of-the-art technological platform, making it possible to bring together French health data assets to guarantee easy and unified, transparent and secure access. It facilitates interactions between health data producers, users and citizens, under high security conditions, and thus contributes to innovation and to bringing together the digital health ecosystem. We offer a set of services to support the players who contribute to finding tomorrow's solutions to improve the health of citizens: supporting project leaders, building and operating a technological … Type: | 54 | 18 | 45 | 132 |
 | GTP Bioways Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing Type: | 21 | 5 | 20 | 135 |
 | CREAPHARM BIO&PHARMA Contract Packaging & Logistics Organization Biostorage: Securing Biobanking of precious biological samples // Clinical Supply: Managing Clinical Trial Material with agility // Commercial Packaging: Taking up packing and repacking challenges Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP Sourcing and Importation, and Biological sampling kit production | 11 | 2 | 7 | 137 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological … Tags: FrenchTech120 FrenchTech2030 Type: | 34 | 13 | 25 | 137 |
 | NAAREA [Automatic translation follows] Energy is the question of the future for humanity and the planet! The goal of NAAREA is to make the continued development of human activities compatible with the protection of the heritage and heritage of humanity that constitutes the climate of our planet. This purpose depends directly on energy. Achieving the 17 Sustainable Development Goals of the United Nations 2030 Agenda is an absolute necessity for humanity (eradicate poverty, protect the planet, guarantee prosperity). Tags: FrenchTech2030 Type: | 26 | 6 | 18 | 138 |
 | Cathay Capital Cathay Capital, Connecting People to Achieve the Extraodinary About Cathay Capital Group Cathay Capital Group is a global investment firm supporting companies at all stages throughout North America, Asia, Europe and Africa. By helping navigate the opportunities of globalization and sustainable transformation, Cathay is the partner of choice for companies aspiring to lead markets and make a positive impact. Its global platform connects people – from investors and entrepreneurs to management teams and leading corporations – across continents to share knowledge, the tools to scale, and achieve the extraordinary. Founded in 2007 with a strong entrepreneurial heritage, Cathay Capital now … Type: | 44 | 9 | 33 | 143 |
 | Kadans Science Partner Built for innovation At Kadans Science Partner, we are dedicated to bringing visionaries together to address the world's most pressing challenges. Across the diverse landscapes of Europe, we have cultivated a vibrant network of clients, partner organisations, and forward-thinking minds. Our community thrives in the domains of Life Sciences & Health, Food, Energy, and the Digital Economy. Together, we share a commitment to finding innovative solutions to the global challenges that shape our world today. Creating the Future of Science Clusters We invest, develop, and operate specialized assets meticulously designed to complement science clusters throughout Europe. These are not merely … Type: | 10 | 6 | 6 | 151 |
 | ANRS [Automatic translation follows] Coordinate, lead and finance research on HIV, viral hepatitis, STIs, tuberculosis and emerging areas ANRS (France REcherche Nord&Sud Sida-hiv Hépatites) is the French research agency for HIV/AIDS and viral hepatitis. Founded in 1988, it mobilizes researchers from the North and the South, from all disciplines, and whatever their affiliations, around scientific questions. Research, HIV/AIDS, Viral hepatitis, Sexually transmitted infections, Tuberculosis, Covid-19, Emerging diseases, Arboviruses, Viral hemorrhagic fevers, Emerging respiratory infections, and One Health Type: | 26 | 7 | 16 | 153 |
 | Aliri We deliver data for life > Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions. MALDI Imaging, ADME analysis, Mass Spectrometry Imaging, Preclinical services, Molecular Imaging, Biodistribution, … Type: | 8 | 5 | 3 | 154 |
 | L'Institut Paris Region ex IAU île-de-France Digital transition, climate change, urban resilience, smart mobility, innovative ecosystems, sustainable development, collaborative economy, biodiversity, urban agriculture... In a fast-changing world, the 200 experts of the Institut Paris Region explore all dimensions of regional and metropolitan life to help local decision-makers improve the quality of life and plan for the future. Our agency works for the Paris Region’s authorities and other cities worldwide. urbanisme, transports, mobilités, environnement, biodiversité, énergie, climat, déchets, économie, démographie, habitat, sécurité, prévention, santé, sport, planification, gouvernance, patrimoine, and paysage Type: | 56 | 20 | 33 | 154 |
 | Pramex International [Automatic translation follows] To establish yourself abroad by creating a subsidiary or acquisition Pramex International supports French start-ups, SMEs and mid-sized companies in their projects to establish themselves abroad, through the creation of a subsidiary or acquisition. -We assist our clients during the creation of their international subsidiary(ies), then in their daily administrative management(s): accounting, taxation, human resources, life social, reporting, etc. - We also advise French SMEs and mid-sized companies in their international acquisition projects on operations of €5 to €150 million (transaction value). With an integrated network of 17 locations spread across 13 countries (Europe, United States, Brazil, … | 15 | 5 | 11 | 164 |
 | Kayentis Simplify your clinical trial experience Kayentis, a global provider of eCOA (electronic Clinical Outcome Assessment) and Decentralized Clinical Trial solutions (DCTs), helps pharma, biotech and CROs bring simplicity, efficiency and quality to the collection of clinical trial data from both patients and sites. Since 2005, Kayentis has been active in clinical development, with a strong specialization in eCOA solutions for phases I-IV across a broad range of therapeutic areas. Over the years, it has developed a full range of services and has enlarged its portfolio beyond eCOA solutions to support the new normal of decentralized and hybrid trials. The company … Type: | 6 | 5 | 2 | 166 |
 | CNOUS (centre national des oeuvres universitaires et scolaires) [Automatic translation follows] Placed under the supervision of the Ministry of Higher Education and Research, the National Center for University and School Work manages the CROUS network. Its objective is to give all students the same chances of access and success in higher education by supporting their daily lives. To accomplish its mission, the CNOUS benefits from an original positioning at the head of a network made up of 28 regional centers (CROUS), 16 local centers (CLOUS) and more than 40 branches which offer students, on the ground, services Proximity. The CNOUS ensures the coherence and management of the network, … Type: | 40 | 8 | 12 | 168 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 7 | 3 | 5 | 172 |
 | Portzamparc Groupe BNP Paribas [Automatic translation follows] Portzamparc, a French leader in stock market support for private clients, management companies and SMEs. A historic player in the financial markets, Portzamparc has more than 150 years of experience in the stock market business. Portzamparc develops a triple advisory and intermediary activity with individuals, but also institutional investors and companies, for which it carries out financial operations (IPOs, capital increases, etc.) and manages liquidity contracts. The subsidiary Portzamparc Gestion is specially dedicated to mandate management and markets a wide range of funds responding to different investment strategies. A strong conviction: maintain the fundamental role of the … Type: | 41 | 5 | 29 | 174 |
 | ANDRH - Association Nationale des DRH [Automatic translation follows] The reference community for HR managers and HR professionals! Join us ! Created in 1947, ANDRH is a 1901 law association serving human resources professionals, representing companies and organizations in all sectors of activity and of all sizes, public and private, national and international. With more than 5,000 members, organized into 80 local groups, including 18 in Ile-de-France, it is the largest community of human resources professionals in France. For more than sixty years, ANDRH has anticipated and supported the evolution of human resources professions and has become, over the years, the community of reference in the … Type: | 55 | 19 | 37 | 176 |
 | Institut national du cancer [Automatic translation follows] Let's accelerate progress against cancer The National Cancer Institute (INCa) is the State's health and scientific expertise agency in cancerology, responsible for coordinating actions to combat cancer. Created by the public health law of August 9, 2004, the Institute is placed under the joint supervision of the Ministry of Social Affairs, Health and Women's Rights, and the Ministry of Higher Education and Research. The National Cancer Institute is constituted in the form of a public interest group (GIP) which brings together the State, the major associations fighting against cancer, the health insurance funds, the research and hospital … Type: | 57 | 28 | 34 | 180 |
 | Baracoda Group We believe Health is a practice. And Tech its enabler. We build daily practices. We build Daily Healthtech. With offices in New York, Paris, and Shanghai, Baracoda is a global leader in daily healthtech, led by entrepreneurs and tech experts who are passionate about health and willing to contribute to improving health globally. The company’s partners include award-winning industry leaders such as Wella and Colgate. Baracoda is creating a new era where health is a long end journey and a daily practice—and tech is its enabler. For everybody. Everyday. IoT, Hardware design, Product innovation, Software development, AI, Data science, Generative … Type: | 25 | 7 | 24 | 182 |
 | DBV Technologies On a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the … | 1 | 1 | 0 | 184 |
 | Lifen Developing cutting-edge healthcare Operating Systems for better care, together. Lifen develops operating systems for the healthcare sector that aim to positively reshape the key components of interoperability, data security, reliability, and compliance standards for digital health. Using the best Artificial Intelligence has to offer, we craft and train algorithms that reliably and automatically structure and integrate health information for a truly complete and dependable system of record that allows for more informed decision-making and diagnosis. Our interoperability platform also simplifies market access for digital health applications worldwide, thanks to API connectors that enable third-party application data to connect to any … Tags: FrenchTech120 FrenchTech2030 Type: | 48 | 18 | 33 | 185 |
 | GIE SESAM-Vitale [Automatic translation follows] The SESAM-Vitale GIE has a rich history marked by innovation. Created in 1993, the Economic Interest Group is today made up of all compulsory health insurance plans and the main complementary health insurance organizations. At the heart of secure exchanges between healthcare professionals and health insurance, he is first entrusted with the program for dematerializing care sheets. Since then, the GIE SESAM-Vitale has established itself as a major player in health information systems. He participates in some of the most significant innovations in the French health system. This is the case with the Vitale card, as well … Type: | 22 | 5 | 17 | 196 |
 | Humans Matter [Automatic translation follows] International cognitive design company #paris #lyon #grenoble #toulouse #hongkong #newyork #philadelphia Humans Matter is a cognitive design company whose mission is to support the transition of behaviors in the environments of work, health, education and Society. Because the world suffers from its inability to act, Humans Matter innovates and designs solutions that act on the capacity to act and whose effectiveness can be measured scientifically. Humans Matter acts on the capacity to act of individuals and collectives to: - Succeed in various business transformations - Increase the therapeutic effectiveness of a treatment course - Acquire the skills … Type: | 23 | 4 | 18 | 200 |
 | ICARE* Icare : Expert dans la maîtrise de la sécurité des produits de santé Groupe ICARE : Votre partenaire expert de la sécurité des produits de santé Avec 30 ans d’expérience, le Groupe ICARE se distingue comme un leader en matière de normalisation et de réglementation internationale. Nous guidons les acteurs du secteur de la santé à travers le complexe paysage réglementaire, assurant que chaque dispositif et produit de santé est commercialisé en toute conformité et sécurité. Notre expertise couvre un large éventail de services essentiels pour garantir l’excellence et la conformité de vos produits : • Biocompatibilité et Toxicologie : … Type: | 16 | 4 | 15 | 201 |
 | Orchard Therapeutics Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy. At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases. We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment. In 2018, the company acquired GSK’s rare disease … Type: | 2 | 2 | 0 | 204 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 20 | 10 | 9 | 211 |
 | CMI Unraveling complex issues is an art. Our strategy consulting firm is recognized for its ability to deal with complex issues. We believe this skill to be a form of art; because it requires talent, method, inspiration, creativity and discipline; because we often work at the edge of our clients’ own knowledge, in a highly critical but often murky area, where problems are complex but nevertheless require simple solutions. Our method is based on two fundamental principles: analytical rigor and empirical validation. We uncompromisingly apply logical reasoning and a strong grounding in reality on each project. We provide strategic recommendations while … Type: | 14 | 2 | 6 | 222 |
 | Calliditas Therapeutics Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. Calliditas is a specialty pharmaceutical company developing high value products for patients with significant unmet medical needs. With a highly experienced, dynamic management team, Calliditas draws on its extensive experience of pharmaceutical development and marketing to efficiently identify and progress valuable and de-risked products. Type: | 5 | 2 | 0 | 228 |
 | Agent We’re a full service brand and comms agency, committed to making good work. Studios in LPL and MCR. We’re a full service brand and comms agency, committed to making good work. Proudly training the next generation of talent via Agent Academy. With studios in Liverpool and Manchester. Creative, Strategy & Planning, and Communications | 5 | 1 | 3 | 231 |
 | Hoppen [Automatic translation follows] Time to Care In 2018, Télécom Santé evolved and became Hoppen - Time to Care to support its own transformation. Since 2011, we have been putting our technological expertise at the service of healthcare establishments through a range of products and services designed, developed and controlled from start to finish (installation, supervision and scalable maintenance) by our teams. Global but personalized, our approach to the Digital Hospital, combined with our professional know-how, allows you to calmly consider the implementation of innovative, simple and intuitive tailor-made solutions. With our solutions, we help all stakeholders in the care pathway: … Tags: FrenchTech2030 Type: | 54 | 10 | 46 | 235 |
 | Median Technologies Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonisTM, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are … Type: | 18 | 7 | 8 | 237 |
 | ELITYS [Automatic translation follows] A new experience of the Council Elitys has been supporting its clients in their projects in Industry and Life Science for over 15 years. From industrialization to continuous improvement, our engineers work in close collaboration with the internal teams of partner companies. Type: | 2 | 0 | 2 | 249 |
 | Bryan, Garnier & Co The European Growth Investment Bank About Bryan, Garnier & Co Founded in 1996, Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors. We partner with clients for the long term throughout their lifecycle, providing them access to public and private capital, M&A advisory with flawless execution and differentiated research insights. Clients benefit from our relentless commitment, unparalleled knowledge of these strategically important sectors and strong relationships with investors - from private equity and venture capital to institutional investors across the US, Europe and Asia. Our corporate clients are disruptors focused … Type: | 17 | 4 | 15 | 266 |
 | Grand Paris Sud Est Avenir // GPSEA [Automatic translation follows] Act daily and for tomorrow Grand Paris Sud Est Avenir is one of the twelve Territorial Public Establishments (EPT) of the Greater Paris Metropolis created on January 1, 2016. It brings together the former intercommunalities of the Plaine Central of Val-de-Marne, Haut-Val- de-Marne and Plateau Briard as well as the town of Bonneuil-sur-Marne. Its headquarters is located in Créteil, prefecture of the Val de Marne department. GPSEA stretches from the gates of Paris to the wooded arc of the south-east of Ile-de-France and the beginning of the agricultural plateau of Brie. It is thus made up of … Type: | 33 | 6 | 28 | 274 |
 | Fédération hospitalière de France (FHF) [Automatic translation follows] The French Hospital Federation represents public hospitals and medico-social establishments Created in 1924, the French Hospital Federation (FHF) brings together more than 1,000 public health establishments (hospitals) and as many medico-social structures (retirement homes and independent specialized reception homes), i.e. almost all of the public sector establishments. This legitimacy and its national dimension make the FHF a leading player in the world of health, a player all the more listened to because it is truly trans-political, as evidenced by the composition of its board of directors. 'administration. The FHF fulfills a triple function of promotion, information and … Type: | 52 | 26 | 27 | 277 |
 | LPA-CGR avocats [Automatic translation follows] Create new balances together. LPA-CGR Avocats is one of the leading independent French business firms, made up of more than 230 lawyers and legal professionals spread across 12 offices around the world (in Europe, Asia, Africa and the Middle East), including 42 associated with Paris. LPA-CGR lawyers assist its clients in all areas of business law, both in advice and litigation. This capacity for mobilization allows its clients to benefit from the skills and expertise necessary to anticipate and resolve complex situations. LPA-CGR lawyers offers specialists in each area of law and in the main sectors of … Type: | 14 | 3 | 14 | 284 |
Startup